Chando Valuation, Funding & Investors

Chando is valued at $1B as of October 2025.

Last Chando valuation

$1B

Undisclosed stage · Oct 2025

Last Chando funding round

$104M

Undisclosed stage · Oct 2025

Cumulative funding Chando raised

$104M

across 1 funding round

Key investors in Chando

Chando Overview

About Chando

Chando is a Shanghai-based skincare brand that creates facial masks, serums, and creams using Himalayan glacial water, peony extracts, and biotechnology processes adapted for Chinese skin concerns like sensitivity and pigmentation.


Founded

2001

HQ

ChinaShanghai

Status

Privately held

Customer focus

B2C

Revenue model

Product sales

Valuation

$1B (Oct 2025)

Chando Valuation

Chando is currently valued at $1B, based on its undisclosed-stage round in October 2025.

The $104M round was led by Harvest Capital and L'Oreal.

Chando valuation by funding round

Chando valuation by funding round
DateStageValuation
Oct 2025Undisclosed stage$1B

Chando Funding History

Chando has raised a total of $104M across 1 funding round.

Chando funding rounds

Chando funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Oct 2025Undisclosed stageHarvest Capital (lead); L'Oreal (lead)$104M$1BCHANDO Group, founded in 2001, completed a CNY 300 million (USD 40 million) financing round on October 10, 2025, with private equity firm Harvest Capital leading the investment and L'Oréal participating as a strategic partner. The company ranks as the third-largest Chinese cosmetics company by retail sales as of 2024 according to Frost & Sullivan, with its flagship CHANDO brand consistently ranking among the top two Chinese beauty brands since 2013. CHANDO Group operates a vertically integrated business encompassing raw material sourcing, research and development, manufacturing, and distribution across multiple brands including CHANDO, Perfection Research, Chunxia, Meisu, and Jichu, covering skincare, makeup, personal care, men's grooming, and baby care categories. The company maintains a fully integrated digital operating system and strong direct-to-consumer channels, with online sales accounting for approximately 68.8% to 69% of total revenue, driven primarily by content-driven e-commerce platforms. Harvest Capital's involvement since 2021 has focused on strategic support, helping optimize the company's ROE-centered budgeting system, strengthen DTC performance, and develop a five-year strategic roadmap aimed at expanding market leadership and preparing for an eventual public listing. L'Oréal's participation reflects its broader strategy of investing in mid-market Chinese beauty brands with natural ingredient positioning, complementing the company's premium luxury offerings and supporting its long-term growth in China's competitive consumer market.

Who has invested in Chando?

2 investors have backed Chando across its funding rounds, including Harvest Capital and L'Oreal.

Lead investors include Harvest Capital and L'Oreal.


Chando Investors

Investors in Chando by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 2 Chando investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Chando Competitors

Chando competitors include listed companies like Cosmecca Korea and Chicmax Cosmetic, and private ones like Augustinus Bader, Haydon, KKW Beauty and Mamaearth.

Public and private companies comparable to Chando
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Augustinus BaderUnited KingdomLondonPrivate$100M-$1B10.0x
HaydonChinaShanghaiPrivate--$1B-
KKW BeautyUnited StatesLos Angeles, CAPrivate$100M-$1B10.0x
MamaearthIndiaGurgaonPrivate$100M-$1B10.0x
Cosmecca KoreaSouth KoreaSouth KoreaPublicly listed$467M$71M$1B2.1x
Chicmax CosmeticChinaChinaPublicly listed$1.4B$235M$1.1B0.8x

Chando Public Comps

Chando is still privately-owned, but its public comps include Cosmecca Korea, Chicmax Cosmetic, Procter & Gamble Health, Mega Lifesciences, T Hasegawa, Sarantis Group, ODDITY Tech, Menicon, Safilo Group and Synsam.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Cosmecca Korea$467M$71M2.5x2.1x16.5x12.9x
Chicmax Cosmetic$1.4B$235M0.8x0.8x4.5x7.3x
Procter & Gamble Health$144M$48M6.4x6.0x19.1x18.3x
Mega Lifesciences$425M$82M2.0x1.9x10.2x8.4x
T Hasegawa$472M$96M1.5x1.4x7.2x-
Sarantis Group$690M$104M1.3x1.3x8.7x8.3x
ODDITY Tech$810M$131M1.5x1.8x9.6x18.3x
Menicon$807M$131M1.4x1.4x8.8x8.3x

This data is available for Pro users. Sign up to see all Chando competitors and their valuation data.

Start Free Trial

Common questions about Chando

When was Chando founded?Chando was founded in 2001.
Where is Chando headquartered?Chando is headquartered in Shanghai, China.
Is Chando publicly listed?No, Chando is a private, VC-backed company.
What is Chando's valuation?Chando was last valued at $1B in its undisclosed-stage round in October 2025.
How much funding has Chando raised?Chando has raised $104M across 1 funding round.
What was Chando's last funding round?Chando's last funding round was a $104M undisclosed-stage round in October 2025, led by Harvest Capital and L'Oreal.
Who are Chando's investors?Chando's investors include L'Oreal and Harvest Capital.
Which companies are comparable to Chando?Companies comparable to Chando include Augustinus Bader, Haydon, KKW Beauty, Mamaearth, Cosmecca Korea and Chicmax Cosmetic.

See companies similar to Chando

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial